• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
H.C. Wainwright analyst maintains buy rating on Rani Therapeutics
12:02
Rani Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.1165 (forecast USD -0.1233)
04:00
Rani Therapeutics released FY2025 9 Months Earnings on November 6 (EST), with actual revenue of USD 172K and EPS of USD -0.5132
04:00
Nov6
Rani Therapeutics and Chugai Collaborate and Initiate RT-114 Phase 1 Trial
22:45
Oct28
Rani Therapeutics Director Mir A. Imran Buys $1.25 Million in Stock
02:06
Oct23
Rani Therapeutics Secures $60.3 Million in Oversubscribed Private Placement
20:22

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.412 M, EPS -0.1165

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.692 M, EPS -0.1831

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 172 K, Net Income -7.264 M, EPS -0.2172

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More